Showing papers by "Michael T. Lin published in 2007"

TL;DR: Evidence is provided that treatment of AD mutant neuroblastoma cells or primary neurons with Aβ antibodies decreases levels of intracellular Aβ, and treatment with A β antibodies protects against synaptic alterations that occur in APP mutant neurons.